Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Monoclonal antibodies and other biologic agents in the treatment of asthma Long AAMAbs 2009[May]; 1 (3): 237-46Asthma represents a syndrome of airway inflammatory diseases with complex pathology. The immunologic pathogenesis is being increasingly revealed and provides opportunity for targeted biological intervention. Current experience with immunomodulators as targeted therapy in asthma is described in this literature review. Targeted therapies have included strategies to activate dendritic cells through the TLR-9 receptors, to interrupt the action of T(H)2 cytokines with cytokine blockers and monoclonal antibodies, to promote development of T(H)1 responses, to block IgE mediated pathways and to block TNFalpha. Omalizumab is the only biological therapy that has an approved indication in asthma at this time. An improved understanding of the heterogeneity of asthma should allow for specific targeting of different disease phenotypes specific therapies including immunomodulators.|*Immunomodulation[MESH]|Animals[MESH]|Antibodies, Anti-Idiotypic[MESH]|Antibodies, Monoclonal, Humanized[MESH]|Antibodies, Monoclonal/therapeutic use[MESH]|Asthma/immunology/*therapy[MESH]|Biological Factors/immunology/*therapeutic use[MESH]|Cytokines/antagonists & inhibitors[MESH]|Dendritic Cells/*drug effects/immunology[MESH]|Humans[MESH]|Immunoglobulin E/immunology[MESH]|Omalizumab[MESH]|Th2 Cells/*drug effects/immunology[MESH]|Toll-Like Receptor 9/agonists[MESH]|Tumor Necrosis Factor-alpha/antagonists & inhibitors[MESH] |
